Cargando…

Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell–Depleted Patients

Twenty-five B-cell–depleted patients (24 following anti-CD19/20 therapy) diagnosed with coronavirus disease 2019 had been symptomatic for a median of 26 days but remained antibody negative. All were treated with convalescent plasma with high neutralizing antibody titers. Twenty-one (84%) recovered,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gharbharan, Arvind, GeurtsvanKessel, Corine H, Jordans, Carlijn C E, Blaauw, Marc, van der Klift, Marjolein, Hassing, Robert-Jan, Smits-Zwinkels, Marijn, Meertens, Maaike, van den Hout, Ella C, de Man, Anne Marie, Hageman, Ilse, Bogers, Susanne, van der Schoot, C Ellen, Swaneveld, Francis, Anas, Adam A, Rokx, Casper, Rijnders, Bart J A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406883/ https://www.ncbi.nlm.nih.gov/pubmed/34293119 http://dx.doi.org/10.1093/cid/ciab647

Ejemplares similares

Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial
por: Gharbharan, Arvind, et al.
Publicado: (2023)

Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
por: Raadsen, Matthijs P., et al.
Publicado: (2021)

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
por: Gharbharan, Arvind, et al.
Publicado: (2021)

Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients
por: Millat-Martinez, Pere, et al.
Publicado: (2022)

High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients
por: Huygens, Sammy, et al.
Publicado: (2023)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study
por: Hullegie, Sebastiaan J., et al.
Publicado: (2017)

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2020)

Evaluating novel COVID-19 vaccines in the current chapter of the pandemic
por: GeurtsvanKessel, Corine H, et al.
Publicado: (2022)

Reply to: Comment on: Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Whole-Blood Testing for Diagnosis of Acute Zika Virus Infections in Routine Diagnostic Setting
por: Voermans, Jolanda J.C., et al.
Publicado: (2019)

COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023)

Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection
por: Neyt, Katrijn, et al.
Publicado: (2016)

Tertiary lymphoid organs in infection and autoimmunity
por: Neyt, Katrijn, et al.
Publicado: (2012)

Brain stem encephalitis is a rare complication of COVID-19
por: Shamier, Marc C., et al.
Publicado: (2023)

Understanding the association between sleep, shift work and COVID‐19 vaccine immune response efficacy: Protocol of the S‐CORE study
por: Lammers‐van der Holst, Heidi M., et al.
Publicado: (2021)

Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?
por: de Jong, Florus C., et al.
Publicado: (2023)

Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors
por: Vinkenoog, Marieke, et al.
Publicado: (2022)

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
por: Steenhuis, Maurice, et al.
Publicado: (2021)

SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence
por: den Hartog, Gerco, et al.
Publicado: (2020)

From more testing to smart testing: data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020
por: van Beek, Janko, et al.
Publicado: (2022)

SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
por: Geers, Daryl, et al.
Publicado: (2021)

Rabies virus uniquely reprograms the transcriptome of human monocyte-derived macrophages
por: Embregts, Carmen W.E., et al.
Publicado: (2023)

Dried blood spot cards: A reliable sampling method to detect human antibodies against rabies virus
por: Doornekamp, Laura, et al.
Publicado: (2020)

Complete Genome Characterization of Eight Human Parainfluenza Viruses from the Netherlands
por: Phan, My V. T., et al.
Publicado: (2019)

Genomic sequence of yellow fever virus from a Dutch traveller returning from the Gambia-Senegal region, the Netherlands, November 2018
por: Phan, My VT, et al.
Publicado: (2019)

Ongoing rabies outbreak in dogs of unprecedented scale and human cases in Nelson Mandela Bay Municipality, South Africa, up to 13 February 2022
por: Ravensberg, Matthijs F, et al.
Publicado: (2022)

Shedding of Yellow Fever Virus From an Imported Case in the Netherlands After Travel to Brazil
por: Phan, My V T, et al.
Publicado: (2020)

Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
por: Langerak, Thomas, et al.
Publicado: (2021)

Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories
por: van den Beld, Maaike J. C., et al.
Publicado: (2021)

Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition
por: de Joode, K., et al.
Publicado: (2021)

Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis
por: Meijer, Wouter J., et al.
Publicado: (2016)

Both Conventional and Interferon Killer Dendritic Cells Have Antigen-Presenting Capacity during Influenza Virus Infection
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2009)

Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination
por: Jongkees, Marlou J, et al.
Publicado: (2022)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022)

Timing and sequence of vaccination against COVID-19 and influenza – Author's reply
por: Dulfer, Elisabeth A., et al.
Publicado: (2023)

SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany
por: Hijnen, DirkJan, et al.
Publicado: (2020)

Street RABV Induces the Cholinergic Anti-inflammatory Pathway in Human Monocyte-Derived Macrophages by Binding to nAChr α7
por: Embregts, Carmen W. E., et al.
Publicado: (2021)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

Enhanced Enterovirus D68 Replication in Neuroblastoma Cells Is Associated with a Cell Culture-Adaptive Amino Acid Substitution in VP1
por: Sooksawasdi Na Ayudhya, Syriam, et al.
Publicado: (2020)

Erratum for Sooksawasdi Na Ayudhya et al., “Enhanced Enterovirus D68 Replication in Neuroblastoma Cells Is Associated with a Cell Culture-Adaptive Amino Acid Substitution in VP1”
por: Sooksawasdi Na Ayudhya, Syriam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ipjimjfe1fnogtntmd5tt4gjgv